EcoDrugPlus

Glutamate Metabotropic Receptor 3

Ensembl ID : ENSECRG00000004294
Gene Symbol: GRM3
3 Cross references
213 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSECRG00000003638
Gene Symbol: GRM5
3 Cross references
290 Possible Orthologues:

Glutaminase

Ensembl ID : ENSECRG00000006167
Gene Symbol: GLS
3 Cross references
312 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha A

Ensembl ID : ENSECRG00000022299
Gene Symbol: GSK3AA
1 Cross references
259 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSECRG00000005736
Gene Symbol: GSK3B
3 Cross references
244 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor 1

Ensembl ID : ENSECRG00000003574
Gene Symbol: GNRHR1
1 Cross references
242 Possible Orthologues:

Granzyme B(G,h)-Like

Ensembl ID : ENSECRG00000018130
Gene Symbol: LOC114661558
2 Cross references
986 Possible Orthologues:

Granzyme B(G,h)-Like

Ensembl ID : ENSECRG00000019808
Gene Symbol: LOC114662717
2 Cross references
986 Possible Orthologues:

Granzyme-Like Protein 1

Ensembl ID : ENSECRG00000019690
Gene Symbol: LOC114662718
2 Cross references
986 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSECRG00000009366
Gene Symbol: GHRHR
3 Cross references
193 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSECRG00000006465
Gene Symbol: GHSR
3 Cross references
211 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSECRG00000005340
Gene Symbol: GUCY1A1
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).